Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Buy
62
MMC Quote, Financials, Valuation and Earnings
Last price:
$233.26
Seasonality move
:
3.92%
Day range:
$226.83 - $234.76
52-week range:
$196.17 - $248.00
Dividend yield:
1.4%
P/E ratio:
28.49x
P/S ratio:
4.73x
P/B ratio:
8.59x
Volume:
2.5M
Avg. volume:
2.3M
1-year change:
17.14%
Market cap:
$114.6B
Revenue:
$24.5B
EPS (TTM):
$8.19
Analysts' Opinion
-
Consensus RatingMarsh & McLennan Companies has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 12 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $237.80, Marsh & McLennan Companies has an estimated upside of 1.91% from its current price of $233.34.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $181.02 representing 22.42% downside risk from its current price of $233.34.
Fair Value
-
According to the consensus of 16 analysts, Marsh & McLennan Companies has 1.91% upside to fair value with a price target of $237.80 per share.
MMC vs. S&P 500
-
Over the past 5 trading days, Marsh & McLennan Companies has underperformed the S&P 500 by -4.1% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Marsh & McLennan Companies does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Marsh & McLennan Companies has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Marsh & McLennan Companies reported revenues of $6.1B.
Earnings Growth
-
Marsh & McLennan Companies has grown year-over-year earnings for 8 quarters straight. In the most recent quarter Marsh & McLennan Companies reported earnings per share of $1.59.
Enterprise value:
132.3B
EV / Invested capital:
--
Price / LTM sales:
4.73x
EV / EBIT:
21.41x
EV / Revenue:
5.41x
PEG ratio (5yr expected):
3.25x
EV / Free cash flow:
33.20x
Price / Operating cash flow:
29.05x
Enterprise value / EBITDA:
19.11x
Gross Profit (TTM):
$10.5B
Return On Assets:
8.1%
Net Income Margin (TTM):
16.6%
Return On Equity:
30.77%
Return On Invested Capital:
14.58%
Operating Margin:
18.82%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $20.7B | $22.7B | $24.5B | $5.6B | $6.1B | |
| Gross Profit | $8.6B | $9.6B | $10.5B | $2.3B | $2.4B | |
| Operating Income | $4.3B | $5.3B | $5.8B | $1.1B | $1.1B | |
| EBITDA | $5.3B | $6.3B | $6.9B | $1.4B | $1.4B | |
| Diluted EPS | $6.02 | $7.53 | $8.19 | $1.52 | $1.59 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $8.2B | $8.3B | $19B | $21.7B | $22.1B | |
| Total Assets | $33B | $34.4B | $44.1B | $48B | $56.5B | |
| Current Liabilities | $6.6B | $6.7B | $17.8B | $19.8B | $19.5B | |
| Total Liabilities | $23.8B | $23.2B | $33.4B | $35.7B | $42.9B | |
| Total Equity | $9.3B | $11.2B | $10.7B | $12.4B | $13.5B | |
| Total Debt | $11.3B | $11B | $11.5B | $13.5B | $19.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3.5B | $4.3B | $4.3B | $1.8B | $2B | |
| Cash From Investing | -$850M | -$1.4B | -$8.8B | -$474M | -$7.6B | |
| Cash From Financing | -$1B | -$1.1B | $4.5B | -$2.3B | $6.3B | |
| Free Cash Flow | $3B | $3.8B | $4B | $1.7B | $1.9B | |
MMC
Sector
Market Cap
$114.6B
$561.8M
Price % of 52-Week High
94.09%
79.49%
Dividend Yield
1.4%
2.13%
Shareholder Yield
0.84%
3.67%
1-Year Price Total Return
17.14%
2.88%
Beta (5-Year)
0.849
0.555
Dividend yield:
1.4%
Annualized payout:
$3.05
Payout ratio:
37.27%
Growth streak:
15 years
Technicals
8-day SMA
Buy
Level
$231.77
200-day SMA
Buy
Level
$223.48
Bollinger Bands (100)
Buy
Level
215.54 - 234.9
Chaikin Money Flow
Buy
Level
682.1M
20-day SMA
Sell
Level
$235.07
Relative Strength Index (RSI14)
Sell
Level
49.86
ADX Line
Sell
Level
29.83
Williams %R
Neutral
Level
-47.7992
50-day SMA
Buy
Level
$231.90
MACD (12, 26)
Sell
Level
-0.65
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Neutral
Level
260.1M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9349)
Sell
CA Score
(Annual)
Level (-0.9225)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (0.104)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
Stock Forecast FAQ
In the current month, MMC has received 4 Buy ratings 12 Hold ratings, and 0 Sell ratings. The MMC average analyst price target in the past 3 months is $237.80.
-
Where Will Marsh & McLennan Companies Stock Be In 1 Year?
According to analysts, the consensus estimate is that Marsh & McLennan Companies share price will rise to $237.80 per share over the next 12 months.
-
What Do Analysts Say About Marsh & McLennan Companies?
Analysts are divided on their view about Marsh & McLennan Companies share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Marsh & McLennan Companies is a Sell and believe this share price will drop from its current level to $181.02.
-
What Is Marsh & McLennan Companies's Price Target?
The price target for Marsh & McLennan Companies over the next 1-year time period is forecast to be $237.80 according to 16 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 12 analysts rate the stock a Hold.
-
Is MMC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Marsh & McLennan Companies is a Hold. 12 of 16 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MMC?
You can purchase shares of Marsh & McLennan Companies via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Marsh & McLennan Companies shares.
-
What Is The Marsh & McLennan Companies Share Price Today?
Marsh & McLennan Companies was last trading at $233.26 per share. This represents the most recent stock quote for Marsh & McLennan Companies. Yesterday, Marsh & McLennan Companies closed at $233.34 per share.
-
How To Buy Marsh & McLennan Companies Stock Online?
In order to purchase Marsh & McLennan Companies stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
